EP1264601A3 - Treatment of a coronary condition by delivery of therapeutics to the pericardial space - Google Patents
Treatment of a coronary condition by delivery of therapeutics to the pericardial space Download PDFInfo
- Publication number
- EP1264601A3 EP1264601A3 EP02014430A EP02014430A EP1264601A3 EP 1264601 A3 EP1264601 A3 EP 1264601A3 EP 02014430 A EP02014430 A EP 02014430A EP 02014430 A EP02014430 A EP 02014430A EP 1264601 A3 EP1264601 A3 EP 1264601A3
- Authority
- EP
- European Patent Office
- Prior art keywords
- treatment
- therapeutics
- delivery
- pericardial space
- coronary condition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 239000003814 drug Substances 0.000 title abstract 3
- 239000008194 pharmaceutical composition Substances 0.000 abstract 2
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 229940124597 therapeutic agent Drugs 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A61K38/1825—Fibroblast growth factor [FGF]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A61K38/1858—Platelet-derived growth factor [PDGF]
- A61K38/1866—Vascular endothelial growth factor [VEGF]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/30—Insulin-like growth factors, i.e. somatomedins, e.g. IGF-1, IGF-2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Immunology (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Urology & Nephrology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Diabetes (AREA)
- Molecular Biology (AREA)
- Endocrinology (AREA)
- Heart & Thoracic Surgery (AREA)
Abstract
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US715895P | 1995-11-01 | 1995-11-01 | |
US7158P | 1995-11-01 | ||
US73884896A | 1996-10-28 | 1996-10-28 | |
US738848 | 1996-10-28 | ||
EP96937820A EP0858322B1 (en) | 1995-11-01 | 1996-11-01 | Treatment of a coronary condition by delivery of therapeutics to the pericardial space |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP96937820A Division EP0858322B1 (en) | 1995-11-01 | 1996-11-01 | Treatment of a coronary condition by delivery of therapeutics to the pericardial space |
Publications (2)
Publication Number | Publication Date |
---|---|
EP1264601A2 EP1264601A2 (en) | 2002-12-11 |
EP1264601A3 true EP1264601A3 (en) | 2003-11-12 |
Family
ID=27238088
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP02014430A Withdrawn EP1264601A3 (en) | 1995-11-01 | 1996-11-01 | Treatment of a coronary condition by delivery of therapeutics to the pericardial space |
Country Status (1)
Country | Link |
---|---|
EP (1) | EP1264601A3 (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7202066B2 (en) | 2002-01-29 | 2007-04-10 | Carrington Laboratories, Inc. | Combination of a growth factor and a protease enzyme |
RU2456543C1 (en) * | 2011-10-05 | 2012-07-20 | Анатолий Павлович Ефимочкин | Method of determining position of laser emitter and apparatus for realising said method |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1992010221A2 (en) * | 1990-12-14 | 1992-06-25 | Mallinckrodt Medical, Inc. | System and method for oxygenation of the heart using subpericardial fluids |
US5269326A (en) * | 1991-10-24 | 1993-12-14 | Georgetown University | Method for transvenously accessing the pericardial space via the right auricle for medical procedures |
WO1994027612A1 (en) * | 1993-05-20 | 1994-12-08 | Baylor College Of Medicine | Genetic therapy for cardiovascular disease |
WO1996000112A1 (en) * | 1994-06-23 | 1996-01-04 | Cormedics Corp. | Vascular treatment method and apparatus |
WO1996039830A1 (en) * | 1995-06-07 | 1996-12-19 | Indiana University Foundation | Pericardial therapeutic and diagnostic agent delivery |
-
1996
- 1996-11-01 EP EP02014430A patent/EP1264601A3/en not_active Withdrawn
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1992010221A2 (en) * | 1990-12-14 | 1992-06-25 | Mallinckrodt Medical, Inc. | System and method for oxygenation of the heart using subpericardial fluids |
US5269326A (en) * | 1991-10-24 | 1993-12-14 | Georgetown University | Method for transvenously accessing the pericardial space via the right auricle for medical procedures |
WO1994027612A1 (en) * | 1993-05-20 | 1994-12-08 | Baylor College Of Medicine | Genetic therapy for cardiovascular disease |
WO1996000112A1 (en) * | 1994-06-23 | 1996-01-04 | Cormedics Corp. | Vascular treatment method and apparatus |
WO1996039830A1 (en) * | 1995-06-07 | 1996-12-19 | Indiana University Foundation | Pericardial therapeutic and diagnostic agent delivery |
Non-Patent Citations (3)
Title |
---|
C. LANDAU ET AL: "Intrapericardial basic fibroblast growth factor induces myocardial angiogenesis in a rabbit model of chronic ischemia", AMERICAN HEART JOURNAL, vol. 129, no. 5, May 1995 (1995-05-01), pages 924 - 931, XP000618320 * |
E. BARR ET AL: "Efficient catheter-mediated gene transfer into the heart using replication-defective adenovirus", GENE THERAPY, vol. 1, 1994, pages 51 - 58, XP000563621 * |
E. G. NABEL: "Gene Therapy for Cardiovascular Disease", CIRCULATION, vol. 91, no. 2, 15 January 1995 (1995-01-15), pages 541 - 548, XP000568740 * |
Also Published As
Publication number | Publication date |
---|---|
EP1264601A2 (en) | 2002-12-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR9306841A (en) | Pharmaceutical composition process for providing an antihistamine treatment which does not induce any significant cardiac arrhythmia in a human patient and use of a composition for the manufacture of a medicine for use in an antihistamine treatment | |
EG19642A (en) | A process for the preparation of oral composition for the treatment of inflammatory bowel diseases | |
CA2245938A1 (en) | Combination therapy for eradicating detectable hcv-rna in patients having chronic hepatitis c infection | |
CA2302700A1 (en) | New use for budesonide and formoterol | |
EP1243267A3 (en) | Amoxycillin and clavulanate containing pharmaceutical formulation | |
KR930702022A (en) | Treatment or prevention of type 1 diabetes by oral administration of insulin | |
NZ508526A (en) | Opioid formulations for treating pain | |
CA2004239A1 (en) | Use of acetyl d-carnitine in the therapeutic treatment of glaucoma, and pharmaceutical compositions useful in such treatment | |
MY111260A (en) | Pharmaceutical composition for the treatment of nicotine dependence | |
CA2046014A1 (en) | Reduction or prevention of skin irritation by drugs | |
WO1999040883A3 (en) | Compositions and methods for the treatment of cystic fibrosis | |
EP1201246A3 (en) | Use of Thrombopoietin as a medicament for the therapy and prevention of thrombocytopenia | |
CA2240717A1 (en) | Method of treating and diagnosing sleep disordered breathing and means for carrying out the method | |
CA2143413A1 (en) | Local Drug Delivery Film, for Periodontal Treatment | |
EP0375628A3 (en) | Use of acetyl l-carnitine in the therapeutic treatment of cataract, and pharmaceutical compositions useful in such treatment | |
CA2143610A1 (en) | Use of norastemizole for the treatment of allergic disorders | |
RU95101385A (en) | Products containing g-csf and tnf-binding protein | |
CA2433833A1 (en) | Use of flumazenil in developing a drug for the treatment of alcohol dependence | |
JP2002544233A5 (en) | ||
MY124465A (en) | Reduction of infarct volume using citicoline | |
WO1994017792A3 (en) | Compositions and methods for transdermal drug delivery | |
WO1999045909A3 (en) | Use of nitrone compounds for the inhibition of angiogenesis | |
JP2002530353A5 (en) | ||
WO1993017691A3 (en) | Pharmaceutical compositions containing monosialoganglioside gm1 or a derivative thereof suitable for the treatment of parkinson's disease | |
WO1996030016A3 (en) | Low dose ridogrel formulations and their use for the treatment of inflammatory bowel diseases |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
AC | Divisional application: reference to earlier application |
Ref document number: 858322 Country of ref document: EP |
|
AK | Designated contracting states |
Kind code of ref document: A2 Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE |
|
PUAL | Search report despatched |
Free format text: ORIGINAL CODE: 0009013 |
|
AK | Designated contracting states |
Kind code of ref document: A3 Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE |
|
17P | Request for examination filed |
Effective date: 20040510 |
|
AKX | Designation fees paid |
Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 20060601 |